Amy K Klapheke1,2, Luis G Carvajal-Carmona3,4, Rosemary D Cress5,6,3. 1. Public Health Institute, Cancer Registry of Greater California, 1825 Bell St, Ste 102, Sacramento, CA, USA. aklapheke@crgc-cancer.org. 2. Department of Public Health Sciences, University of California Davis, Davis, CA, USA. aklapheke@crgc-cancer.org. 3. Population Sciences and Health Disparities Program, University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA. 4. Genome Center and Department of Biochemistry and Molecular Medicine, University of California, Davis, CA, USA. 5. Public Health Institute, Cancer Registry of Greater California, 1825 Bell St, Ste 102, Sacramento, CA, USA. 6. Department of Public Health Sciences, University of California Davis, Davis, CA, USA.
Abstract
BACKGROUND: Gastric cancer is an important cause of death among racial/ethnic minorities in the U.S. The objective of this study was to investigate racial disparities in survival among gastric cancer patients within demographic and disease subgroups. METHODS: Patients diagnosed with invasive epithelial gastric cancer between 2006 and 2015 were identified from the California Cancer Registry. Cox proportional hazards regression was used to identify factors associated with survival among non-Hispanic whites (NHWs, n = 7,475), non-Hispanic blacks (NHBs, n = 1,246), Hispanics (n = 6,274), and Asians/Pacific Islanders (APIs, n = 4,204). Survival was compared across race/ethnicity within subgroups of demographic and disease factors. Five-year relative survival was also calculated within subgroups. RESULTS: There were notable differences in patient characteristics by race/ethnicity, but predictors of survival were similar for each group. Overall, APIs (HR = 0.83, 95% CI: 0.79, 0.88, p < 0.0001) and Hispanics (HR = 0.94, 95% CI: 0.90, 0.99, p = 0.0104) had better survival than NHWs, but NHBs and NHWs did not have different prognosis (HR = 1.06, 95% CI: 0.98, 1.15, p = 0.2237). The survival advantage of APIs persisted in nearly every demographic and disease subgroup, but Hispanics and NHBs had similar survival as NHWs in most groups. Race was not a significant predictor of survival among those with public or no insurance and patients with cardia tumors. CONCLUSIONS: There are some differences in survival by race/ethnicity, but race/ethnicity alone cannot explain disparate outcomes in gastric cancer. Future studies, particularly ones that investigate the role of population-specific etiological factors and molecular tumor profiles, are needed to further understand factors associated with survival.
BACKGROUND:Gastric cancer is an important cause of death among racial/ethnic minorities in the U.S. The objective of this study was to investigate racial disparities in survival among gastric cancerpatients within demographic and disease subgroups. METHODS:Patients diagnosed with invasive epithelial gastric cancer between 2006 and 2015 were identified from the California Cancer Registry. Cox proportional hazards regression was used to identify factors associated with survival among non-Hispanic whites (NHWs, n = 7,475), non-Hispanic blacks (NHBs, n = 1,246), Hispanics (n = 6,274), and Asians/Pacific Islanders (APIs, n = 4,204). Survival was compared across race/ethnicity within subgroups of demographic and disease factors. Five-year relative survival was also calculated within subgroups. RESULTS: There were notable differences in patient characteristics by race/ethnicity, but predictors of survival were similar for each group. Overall, APIs (HR = 0.83, 95% CI: 0.79, 0.88, p < 0.0001) and Hispanics (HR = 0.94, 95% CI: 0.90, 0.99, p = 0.0104) had better survival than NHWs, but NHBs and NHWs did not have different prognosis (HR = 1.06, 95% CI: 0.98, 1.15, p = 0.2237). The survival advantage of APIs persisted in nearly every demographic and disease subgroup, but Hispanics and NHBs had similar survival as NHWs in most groups. Race was not a significant predictor of survival among those with public or no insurance and patients with cardia tumors. CONCLUSIONS: There are some differences in survival by race/ethnicity, but race/ethnicity alone cannot explain disparate outcomes in gastric cancer. Future studies, particularly ones that investigate the role of population-specific etiological factors and molecular tumor profiles, are needed to further understand factors associated with survival.
Authors: Samir Gupta; Li Tao; James D Murphy; M Constanza Camargo; Eyal Oren; Mark A Valasek; Scarlett Lin Gomez; Maria Elena Martinez Journal: Gastroenterology Date: 2018-09-26 Impact factor: 22.682
Authors: Juan E Corral; Juan J Delgado Hurtado; Ricardo L Domínguez; Marisabel Valdez de Cuéllar; Carlos Balmore Cruz; Douglas R Morgan Journal: J Gastrointest Cancer Date: 2015-03
Authors: Lindsey A Torre; Ann M Goding Sauer; Moon S Chen; Marjorie Kagawa-Singer; Ahmedin Jemal; Rebecca L Siegel Journal: CA Cancer J Clin Date: 2016-01-14 Impact factor: 508.702
Authors: Neal W Wilkinson; James Howe; Greer Gay; Lina Patel-Parekh; Carol Scott-Conner; John Donohue Journal: Ann Surg Oncol Date: 2008-04-05 Impact factor: 5.344
Authors: Ellen T Chang; Scarlett Lin Gomez; Kari Fish; Clayton W Schupp; Julie Parsonnet; Mindy C DeRouen; Theresa H M Keegan; Christina A Clarke; Sally L Glaser Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-02-28 Impact factor: 4.090
Authors: Madison H Williams; Ryan A Williams; Brian Hernandez; Joel Michalek; Dorothy Long Parma; Sukeshi P Arora Journal: J Gastrointest Oncol Date: 2021-08
Authors: Monika Laszkowska; Angela C Tramontano; Judith Kim; M Constanza Camargo; Alfred I Neugut; Julian A Abrams; Chin Hur Journal: Cancer Med Date: 2020-06-23 Impact factor: 4.452
Authors: Michael LaPelusa; Chan Shen; Erin A Gillaspie; Christopher Cann; Eric Lambright; A Bapsi Chakravarthy; Michael K Gibson; Cathy Eng Journal: Cancers (Basel) Date: 2022-07-26 Impact factor: 6.575
Authors: Valentina A Zavala; Paige M Bracci; John M Carethers; Luis Carvajal-Carmona; Nicole B Coggins; Marcia R Cruz-Correa; Melissa Davis; Adam J de Smith; Julie Dutil; Jane C Figueiredo; Rena Fox; Kristi D Graves; Scarlett Lin Gomez; Andrea Llera; Susan L Neuhausen; Lisa Newman; Tung Nguyen; Julie R Palmer; Nynikka R Palmer; Eliseo J Pérez-Stable; Sorbarikor Piawah; Erik J Rodriquez; María Carolina Sanabria-Salas; Stephanie L Schmit; Silvia J Serrano-Gomez; Mariana C Stern; Jeffrey Weitzel; Jun J Yang; Jovanny Zabaleta; Elad Ziv; Laura Fejerman Journal: Br J Cancer Date: 2020-09-09 Impact factor: 9.075